A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity-Reference-Cited by-同舟云学术

A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity

Published:2021-03-08 Issue:5 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Barghout Samir H.^ORCID,Aman Ahmed^ORCID,Nouri Kazem^ORCID,Blatman Zachary,Arevalo Karen,Thomas Geethu E.,MacLean Neil,Hurren Rose,Ketela Troy,Saini Mehakpreet,Abohawya Moustafa,Kiyota Taira^ORCID,Al-Awar Rima,Schimmer Aaron D.

Funder

Leukemia and Lymphoma Society of Canada

Canadian Institutes of Health Research

Princess Margaret Cancer Foundation

Ontario Ministry of Health and Long-Term Care

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/141518/files/pdf

Reference60 articles.

1. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways;Schulman;Nat Rev Mol Cell Biol,2009

2. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment

3. E1 Enzymes as Therapeutic Targets in Cancer

4. Drug discovery in the ubiquitin–proteasome system

5. Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABCG2 shields against epilepsy, relieves oxidative stress and apoptosis via inhibiting the ISGylation of STAT1 and mTOR;Redox Biology;2024-09

2. Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer;Molecular Cancer;2024-06-03

3. Uncovering the bookshelves of CRISPR-based libraries: Advances and applications in cancer studies;Critical Reviews in Oncology/Hematology;2024-04

4. Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy;Acta Pharmaceutica Sinica B;2023-11

5. CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects;Life Sciences;2023-11